Search Results Search Sort by RelevanceMost Recent Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105. In the Literature Jun 2019 Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions Leah Z. G. Rand, DPhil and Zackary Berger, MD, PhD How should evidence be used to interpret and inform whether to accommodate patients’ requests for clinicians with specific traits? AMA J Ethics. 2019;21(6):E505-512. doi: 10.1001/amajethics.2019.505. In the Literature Apr 2016 A Defense of “The Case for Conserving Disability” Jasmine Zahid Rosemarie Garland-Thomson’s argument for disability as a sociocultural resource challenges the commonsense understanding of disability as a deficit. AMA J Ethics. 2016;18(4):399-405. doi: 10.1001/journalofethics.2016.18.4.nlit2-1604. Medicine and Society Feb 2009 The Double Helix and Double-Edged Sword: How the Public Thinks about Genes Jason Schnittker, PhD Virtual Mentor. 2009;11(2):155-160. doi: 10.1001/virtualmentor.2009.11.2.msoc1-0902. In the Literature Feb 2001 Sources of Embryonic Stem Cells for Research Faith Lagay, PhD Virtual Mentor. 2001;3(2):35-36. doi: 10.1001/virtualmentor.2001.3.2.jdsc1-0102. Viewpoint Apr 2010 A Call for Collaborative Action against America’s Greatest Health Threat Richard H. Carmona, MD, MPH All of us who are pursuing solutions to the obesity epidemic face clinical, ethical, and regulatory challenges. First among them is the significant role of individual lifestyle and behavior choices in causing obesity. Virtual Mentor. 2010;12(4):327-330. doi: 10.1001/virtualmentor.2010.12.4.oped1-1004.
Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105.
In the Literature Jun 2019 Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions Leah Z. G. Rand, DPhil and Zackary Berger, MD, PhD How should evidence be used to interpret and inform whether to accommodate patients’ requests for clinicians with specific traits? AMA J Ethics. 2019;21(6):E505-512. doi: 10.1001/amajethics.2019.505.
In the Literature Apr 2016 A Defense of “The Case for Conserving Disability” Jasmine Zahid Rosemarie Garland-Thomson’s argument for disability as a sociocultural resource challenges the commonsense understanding of disability as a deficit. AMA J Ethics. 2016;18(4):399-405. doi: 10.1001/journalofethics.2016.18.4.nlit2-1604.
Medicine and Society Feb 2009 The Double Helix and Double-Edged Sword: How the Public Thinks about Genes Jason Schnittker, PhD Virtual Mentor. 2009;11(2):155-160. doi: 10.1001/virtualmentor.2009.11.2.msoc1-0902.
In the Literature Feb 2001 Sources of Embryonic Stem Cells for Research Faith Lagay, PhD Virtual Mentor. 2001;3(2):35-36. doi: 10.1001/virtualmentor.2001.3.2.jdsc1-0102.
Viewpoint Apr 2010 A Call for Collaborative Action against America’s Greatest Health Threat Richard H. Carmona, MD, MPH All of us who are pursuing solutions to the obesity epidemic face clinical, ethical, and regulatory challenges. First among them is the significant role of individual lifestyle and behavior choices in causing obesity. Virtual Mentor. 2010;12(4):327-330. doi: 10.1001/virtualmentor.2010.12.4.oped1-1004.